MIC Made as Easy as A, B, C, D Kumar Jeetendra | August 31, 2020 In recent years, there has been a growing interest in researching and developing new antimicrobial agents from various sources to combat microbial resistance. Several factors led to this increase, particularly the selection pressure exerted by overuse & misuse of antimicrobial agents which resulted in the emergence of resistant microorganisms. This, in turn, led to increasing …
Preparations on for next phase of clinical trial of’Covaxin’ vaccine Kumar Jeetendra | August 31, 2020 Preparations are underway in a hospital here for the commencement of the second stage of human clinical trial of’Covaxin’,” India’s indigenous COVID-19 vaccine, officials said. “The Phase I of the trial is still continuing as we are planning for the beginning of the Stage II trial soon,” Dr E Venkata Rao, Principal Investigator of the …
Aerogen: An appropriate aerosol drug delivery system for the effective treatment of respiratory illness Kumar Jeetendra | September 1, 2020 No matter what the respiratory illness, for mechanically ventilated or spontaneous breathing patients, Aerogen has the appropriate aerosol drug delivery system for the effective treatment of your patients. The illness includes: 1.COPD 2.Asthma 3.Cystic Fibrosis COPD Chronic Obstructive Pulmonary Disease (COPD) is among the very serious lung diseases prevalent today affecting 65 million people globally. …
Biocartis Expands Collaboration with LifeArc Kumar Jeetendra | September 1, 2020 Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the expansion of its collaboration with LifeArc, a UK based independent medical research charity, with a new agreement aimed at the development of highly innovative prototype assays in the …
Combating Vector Borne Diseases: Approach Through Tropical Medicine and Diagnosis Kumar Jeetendra | September 2, 2020 Seasonal torrential rains and dark and thick vegetation and some other culture thronging upon the possible livelihood in these regions will encounter the wrath of the several vectors (carriers) which bring a myriad of ailments. The easy to go approach of dealing these endemics was to kill the vectors and then if it reached the …
Zydus Cadila gets USFDA gesture for muscle relaxant infusion Kumar Jeetendra | September 2, 2020 Zydus Cadila has obtained final acceptance by the US Food and Drug Administration (USFDA) to advertise Cisatracurium Besylate Injection USP at the potency of 20 milligrams (base)/10 mL (two mg/mL) multiple-dose vial, Cadila Healthcare stated in a regulatory filing on Wednesday. The drug will be produced in Liva plant of Cadila Healthcare Ltd.. Zydus Cadila …
Lupin dispatches generic rheumatoid arthritis drug in US market Kumar Jeetendra | September 2, 2020 Medicine manufacturer Lupin on Wednesday said it has established Leflunomide pills, used to treat rheumatoid arthritis, even in the US marketplace. The business has established the product in 10 mg and 20 mg strengths after receiving the approval by the US Food and Drug Administration (USFDA) before, Lupin said in a statement. The item could …
Spectrum Compact CE Benchtop DNA Analysis Instrument launched by Promega in collaboration with Hitachi High-Tech Kumar Jeetendra | September 3, 2020 Madison, WI USA. (September 1, 2020) Promega today launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system is an integrated DNA analysis instrument that enables life scientists in laboratories of all sizes to perform Sanger sequencing and fragment analysis at the bench. …
Analytik Jena’s New ICP-OES PlasmaQuant 9100 adding clarity, simplicity and confidence to your most delicate analytical routines Kumar Jeetendra | September 3, 2020 With the PlasmaQuant 9100 and the 9100 Elite, Analytik Jena presents the evolution of its ICP-OES portfolio. The new ICP-OES series offers more automation, greater adaptability and shorter analysis times. The PlasmaQuant 9100 series is ideal for laboratories with difficult to analyze sample matrices and a steadily increasing number of samples. The target industries for the …
Protein-based COVID-19 vaccine trial launched by Sanofi and GSK Kumar Jeetendra | September 3, 2020 French drugmaker Sanofi and its British peer GSK have begun a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical firms race to develop treatments against the coronavirus pandemic. Sanofi and GSK said in a joint statement on Thursday they’d begun the”Stage 1/2″ trial for their adjuvanted COVID-19 vaccine, and that they expect to …
Oxytocinergic and vasopressinergic substances in the mind are associated with managing social conduct Kumar Jeetendra | September 4, 2020 In humans, mutations of this gene cause Rett syndrome, a rare disorder of the neural development that causes, among other ailments, a reduction of language and of their capacity to roam, traits of autistic diseases and epilepsy. Nonapeptides, peptide chains with nine amino acids like oxytocin and vasopressin, are found in the cerebral nuclei that …
Intricacy to Clarity: Transforming chromatographic information data useable outcomes Kumar Jeetendra | September 4, 2020 Register for this free-of-charge webinar – 22 September – 8 am and 4 pm (BST) Rapid advances in analytical technologies, such as sample preparation, 1D and 2D chromatographic separation and detection by mass spectrometry, are resulting in a massive increase in the data we get from our analyses. This means we can gain ever increasing …
